首页> 外文期刊>AJNR. American journal of neuroradiology >Cerebrovascular reactivity is a main determinant of white matter hyperintensity progression in CADASIL.
【24h】

Cerebrovascular reactivity is a main determinant of white matter hyperintensity progression in CADASIL.

机译:脑血管反应性是CADASIL中白质高强度进程的主要决定因素。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: Basal total cerebral blood flow (TCBF) and cerebrovascular reactivity (CVR) are assumed to play an important role in the pathophysiology of small-vessel disease. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a unique monogenetic model to study the pathophysiology of arterial small-vessel disease. The aim of this study was to investigate the role of TCBF and CVR in the progression of MR imaging abnormalities in CADASIL. MATERIALS AND METHODS: Basal TCBF was measured in 25 NOTCH3 mutation carriers and 13 control subjects at baseline. CVR after administration of acetazolamide was measured in 14 NOTCH3 mutation carriers and 9 control subjects. Increase in white matter hyperintensities (WMHs), lacunar infarcts, and microbleeds on MR imaging was measured 7 years later. RESULTS: Lower CVR at baseline was associated with larger increase of WMHs (P = .001) but not with a larger increase of lacunar infarcts or microbleeds. TCBF at baseline was not associated with an increase of MR imaging abnormalities. CONCLUSIONS: Decreased CVR is a potential predictor of disease progression as indicated by increasing WMHs in CADASIL.
机译:背景与目的:假定基础小脑总血流量(TCBF)和脑血管反应性(CVR)在小血管疾病的病理生理中起重要作用。具有皮质下梗塞和白脑病的脑常染色体显性遗传性动脉病(CADASIL)是研究动脉小血管疾病病理生理的独特单基因模型。这项研究的目的是调查TCBF和CVR在CADASIL MR影像异常进展中的作用。材料与方法:在基线时测量了25位NOTCH3突变携带者和13位对照受试者的基础TCBF。在14位NOTCH3突变携带者和9位对照组中测量了乙酰唑胺给药后的CVR。 7年后,测量了MR成像中白质高信号(WMH),腔隙性梗塞和微出血的增加。结果:基线时较低的CVR与WMHs的增加较大(P = .001),但与腔隙性梗塞或微出血的增加没有太大关系。基线时的TCBF与MR影像学异常增加无关。结论:CVR降低是疾病进展的潜在预测指标,如CADASIL中WMHs升高所表明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号